Pharvaris is advancing deucrictibant, an oral bradykinin B2-receptor antagonist, in two late-stage trials. Read my analysis ...

Deloitte predicts AI fraud losses could hit $40 billion in the United States by 2027. Can anyone stop these scammers?

The numbers were clear, compelling, and perfectly aligned with the narratives and indices built by Shehu Aminu, an ...